Search for: "DAIICHI PHARMACEUTICALS,INC."
Results 21 - 40
of 83
Sorted by Relevance
|
Sort by Date
22 Jul 2011, 12:06 am
She is suing Johnson & Johnson, Ortho-McNeil Pharmaceutical Inc. and Johnson & Johnson Pharmaceutical Research & Development LLC for negligence, breach of warranties and consumer fraud. [read post]
13 Sep 2007, 3:57 am
Apotex, Inc., et al. [read post]
13 Mar 2014, 2:07 pm
Daiichi Sankyo Inc., Case. [read post]
26 May 2015, 12:53 pm
Indianapolis, Indiana - An Indiana patent attorney for Eli Lilly and Company of Indianapolis, Indiana; Daiichi Sankyo Co., Ltd. of Tokyo, Japan; Daiichi Sankyo, Inc. of Parsippany, New Jersey; and Ube Industries, Ltd of Yamaguchi, Japan filed a federal lawsuit in the Southern District of Indiana alleging that HEC Pharm USA, Inc. of Princeton, New Jersey and HEC Pharm Co. [read post]
17 Apr 2014, 7:43 am
Daiichi Sankyo Inc. consists of female pharmaceutical sales employees. [read post]
1 Dec 2012, 8:00 pm
Separately, as to Ranbaxy's version of Lipitor ( atorvastatin ), note text from BusinessWeek in the postDrugmaker Ranbaxy halts generic Lipitor production : Problem-plagued Ranbaxy Pharmaceuticals Inc. has halted production of generic cholesterol drug Lipitor while it investigates how tiny glass particles got into the ingredients used for dozens of batches of the drug that were recalled in November. [read post]
29 Apr 2015, 11:15 am
This lawsuit adds another two new Defendants, Lupin Ltd. and Lupin Pharmaceuticals, Inc. [read post]
9 Sep 2010, 7:09 pm
Zenith Goldline Pharmaceuticals, Inc., 471 F.3d 1369, 1377-79 (Fed. [read post]
1 Dec 2012, 8:00 pm
Separately, as to Ranbaxy's version of Lipitor ( atorvastatin ), note text from BusinessWeek in the postDrugmaker Ranbaxy halts generic Lipitor production : Problem-plagued Ranbaxy Pharmaceuticals Inc. has halted production of generic cholesterol drug Lipitor while it investigates how tiny glass particles got into the ingredients used for dozens of batches of the drug that were recalled in November. [read post]
14 Jul 2014, 11:28 am
Indianapolis, Indiana - An Indiana patent attorney for Eli Lilly and Company of Indianapolis, Indiana; Daiichi Sankyo Co., Ltd of Tokyo, Japan; Daiichi Sankyo, Inc. of Parsippany, New Jersey; and Ube Industries, Ltd. of Yamaguchi, Japan sued in the Southern District of Indiana alleging that HEC Pharm Co., Ltd. of China and HEC Pharm USA Inc. of Princeton, New Jersey (collectively, "HEC Pharm") infringed Lilly's patented Effient® product, Patent… [read post]
10 Feb 2010, 4:47 pm
Mylan Pharmaceuticals Inc. [read post]
24 Mar 2010, 4:45 am
Synthon Pharmaceuticals, Inc. [read post]
13 May 2010, 4:58 pm
Watson Pharmaceuticals Inc. et al. [read post]
10 Aug 2010, 8:44 pm
Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while judging novelty:… [read post]
8 Jul 2009, 7:04 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Kenya: Manufacturers, public heath interests clash over anti-counterfeit law; AIDS patients to bring Constitutional challenge (Intellectual Property Watch) (Afro-IP) (Intellectual Property Watch) Humira (Adalimumab) – US: Largest patent verdict in history – Abbott to pay $1.67 billion to Centocor because Humira found to… [read post]
2 Dec 2009, 4:31 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: World AIDS Day: Make it happen (Patent Baristas) (IP Watch) Venezuela to examine all pharmaceutical patents (IP tango) General World AIDS Day: Make it happen (Patent Baristas) (IP Watch) Biodiversity negotiations need to allow for flexibility in business, industry says (IP Watch) Brazilian government tailors a bill… [read post]
29 Dec 2009, 9:09 pm
Miller, Vice President of Corporate Business Development, Eli Lilly Reid Leonard, Vice President External Licensing and Business Development, Merck Jules Musling, VP, Johnson & Johnson Carlos Garrido, Finance Director , Head of Strategic Planning and Business Development South America, AstraZeneca Peter Verheyen, VP Business Development, Johnson & Johnson Michael Lytton, EVP Business Development, Biogen Idec Inc Mark Dennish, Vice President, Business Development, Daiichi… [read post]
29 Dec 2009, 9:09 pm
Miller, Vice President of Corporate Business Development, Eli Lilly Reid Leonard, Vice President External Licensing and Business Development, Merck Jules Musling, VP, Johnson & Johnson Carlos Garrido, Finance Director , Head of Strategic Planning and Business Development South America, AstraZeneca Peter Verheyen, VP Business Development, Johnson & Johnson Michael Lytton, EVP Business Development, Biogen Idec Inc Mark Dennish, Vice President, Business Development, Daiichi… [read post]
25 Oct 2008, 12:03 am
Sandoz, Inc (Law360) (Hal Wegner) (Patently-O) (Patent Prospector) (PLI) Cipro (Ciprofloxacin) - US: CAFC finds no antitrust liability for Hatch-Waxman reverse payment settlements: In Re Ciproflaxacin Hydrochloride Antitrust Litigation (IP Law Observer) Lescol (Fluvastatin) - US: Mylan confirms first-to-file patent challenge to Lescol by Novartis (SmartBrief) Levaquin (Levofloxacin) - UK: Levofloxacin SPC valid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd… [read post]
25 Aug 2010, 12:37 am
Watson Pharma, Inc. et al. [read post]
